Nemaura Pharma

Founded in 2005, Nemaura Pharma is a private specialist biotech company focusing on cutting-edge innovative drug formulation and medical device technologies designed to radically improve the way drugs are administered through the skin. The company has secured over £25m (over$30m) in licensing and development payments, and private investment. In addition, Nemaura has been awarded five highly competitive British Government grants, and the Frost & Sullivan 2016 Enabling Technology Leadership Award in Transdermal Drug Delivery, and has patents secured or pending in multiple countries across numerous patent families. The company employs multi-disciplinary teams of scientists and engineers at its headquarters and research facilities in the Advanced Technology Centre on the Loughborough University Science and Enterprise Park (LUSEP) in the United Kingdom.